Product Information
DICLOFENAC POTASSIUM 25 MG CAP is a generic product labeled by Chartwell RX LLC, priced at $2.8071 per EA under NDC 62135046912. Its NADAC has been published 156 times since Jun 14, 2023.
FDA first approved this application on Dec 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Chartwell RX LLCNDC
62135046912
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA210078FDA Approved
12/3/2019
TE Code
AB
On Market Since
11/21/2022
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC POTASSIUM 25 MG CAP has been published 156 times since Jun 14, 2023, and over the history we have for it it has declined 64.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8071 per EA |
|---|---|
| All-time high | $7.8865 (Dec 13, 2023) |
| All-time low | $2.1109 (Jul 23, 2025) |
| 52-week high | $3.3863 |
| 52-week low | $2.2747 |
| Median price | $3.3596 |
| Average price | $4.3268 |
| Largest weekly change | -29.0% (Aug 21, 2024) |
| Weeks tracked | 156 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC POTASSIUM 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC POTASSIUM 25 MG CAP, manufactured by Chartwell RX LLC, is $2.8071 per EA (NDC 62135046912), effective Sep 30, 2026.
How has the price of DICLOFENAC POTASSIUM 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DICLOFENAC POTASSIUM 25 MG CAP has declined 64.4%. It has been tracked across 156 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for DICLOFENAC POTASSIUM 25 MG CAP?
Since Jun 14, 2023, the NADAC for DICLOFENAC POTASSIUM 25 MG CAP has ranged from a low of $2.1109 (Jul 23, 2025) to a high of $7.8865 (Dec 13, 2023), with a median of $3.3596 per EA.
Are there cheaper alternatives to DICLOFENAC POTASSIUM 25 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICLOFENAC POTASSIUM 25 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC POTASSIUM 25 MG CAP?
DICLOFENAC POTASSIUM 25 MG CAP (NDC 62135046912) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.